Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
Quanwei ZhouFei WuWenlong ZhangYouwei GuoXingjun JiangXuejun YanYiquan KePublished in: Journal of cellular and molecular medicine (2024)
Accumulating evidence suggests that a wide variety of cell deaths are deeply involved in cancer immunity. However, their roles in glioma have not been explored. We employed a logistic regression model with the shrinkage regularization operator (LASSO) Cox combined with seven machine learning algorithms to analyse the patterns of cell death (including cuproptosis, ferroptosis, pyroptosis, apoptosis and necrosis) in The Cancer Genome Atlas (TCGA) cohort. The performance of the nomogram was assessed through the use of receiver operating characteristic (ROC) curves and calibration curves. Cell-type identification was estimated by using the cell-type identification by estimating relative subsets of known RNA transcripts (CIBERSORT) and single sample gene set enrichment analysis methods. Hub genes associated with the prognostic model were screened through machine learning techniques. The expression pattern and clinical significance of MYD88 were investigated via immunohistochemistry (IHC). The cell death score represents an independent prognostic factor for poor outcomes in glioma patients and has a distinctly superior accuracy to that of 10 published signatures. The nomogram performed well in predicting outcomes according to time-dependent ROC and calibration plots. In addition, a high-risk score was significantly related to high expression of immune checkpoint molecules and dense infiltration of protumor cells, these findings were associated with a cell death-based prognostic model. Upregulated MYD88 expression was associated with malignant phenotypes and undesirable prognoses according to the IHC. Furthermore, high MYD88 expression was associated with poor clinical outcomes and was positively related to CD163, PD-L1 and vimentin expression in the in-horse cohort. The cell death score provides a precise stratification and immune status for glioma. MYD88 was found to be an outstanding representative that might play an important role in glioma.
Keyphrases
- cell death
- cell cycle arrest
- machine learning
- poor prognosis
- prognostic factors
- toll like receptor
- end stage renal disease
- binding protein
- chronic kidney disease
- papillary thyroid
- genome wide
- ejection fraction
- big data
- squamous cell carcinoma
- single cell
- metabolic syndrome
- squamous cell
- peritoneal dialysis
- skeletal muscle
- bone marrow
- young adults
- weight loss
- cell therapy
- copy number
- nk cells